Shiro Hinotsu

Current Status of Endocrine Therapy for Prostate Cancer in Japan Analysis of Primary Androgen Deprivation Therapy on the Basis of Data Collected by J-CaP (2007)

Hinotsu, Shiro, Akaza, Hideyuki, Usami, Michiyuki, Ogawa, Osamu, Kagawa, Susumu, Kitamura, Tadaichi, ...

Background Based on the data of current status of endocrine therapy for prostate cancer registered in the Japan Study Group of Prostate Cancer (J-CaP), we conducted an analysis of primary androgen...

Three-weekly Docetaxel with Prednisone is Feasible for Japanese Patients with Hormone-refractory Prostate Cancer: A Retrospective Comparative Study with Weekly Docetaxel Alone (2007)

Shimazui, Toru, Kawai, Koji, Miyanaga, Naoto, Kojima, Takahiro, Sekido, Noritoshi, Hinotsu, Shiro, ...

Background We previously reported that weekly treatment with docetaxel alone is useful for and well tolerated by patients with hormone-refractory prostate cancer (HRPC). Here, we compare it with the...

Does Tumor Size or Microvascular Invasion Affect Prognosis in Patients with Renal Cell Carcinoma? (2007)

Miyagawa, Tomoaki, Shimazui, Toru, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma...

Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy (2007)

Miyanaga, Naoto, Akaza, Hideyuki, Hinotsu, Shiro, Joraku, Akira, Oikawa, Takehiro, Sekido, Noritoshi, ...

Objective The present study was undertaken to identify the patients suitable for bladder preservation by analysis of our data. Methods The subjects of this study were all 72 patients with T2–3N0M0...

Does Tumor Size or Microvascular Invasion Affect Prognosis in Patients with Renal Cell Carcinoma? (2007)

Miyagawa, Tomoaki, Shimazui, Toru, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma...

Treatment Outcome of Metastatic Testicular Cancer at a Single Institution in Japan, a Country with Low Incidence of Germ Cell Tumor (2006)

Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...

Background Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...

Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients (2006)

Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...

Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients (2006)

Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...

Treatment Outcome of Metastatic Testicular Cancer at a Single Institution in Japan, a Country with Low Incidence of Germ Cell Tumor (2006)

Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...

Background: Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...

Characteristics of Patients with Prostate Cancer Who Have Initially been Treated by Hormone Therapy in Japan: J-CaP Surveillance (2004)

Akaza, Hideyuki, Usami, Michiyuki, Hinotsu, Shiro, Ogawa, Osamu, Kagawa, Susumu, Kitamura, Tadaichi, ...

Objective: Hormone therapy for prostate cancer has empirically prevailed in Japan. We planned to evaluate the trends and outcome of hormone therapy for establishing an adequate guideline. Methods:...

Weekly Administration of Docetaxel in Patients with Hormone-refractory Prostate Cancer: a Pilot Study on Japanese Patients (2004)

Kojima, Takahiro, Shimazui, Toru, Onozawa, Mizuki, Tsukamoto, Sadamu, Hinotsu, Shiro, Miyanaga, Naoto, ...

Objective: Although treatment of hormone-refractory prostate cancer (HRPC) is difficult, a single-agent weekly dose of docetaxel has been reported as a promising regimen for patients with HRPC. The...

The Limited Efficacy of Methotrexate, Actinomycin D and Cisplatin (MAP) for Patients with Advanced Testicular Cancer (2003)

Miyazaki, Jun, Kawai, Koji, Hayashi, Hitoshi, Onozawa, Mizuki, Tsukamoto, Sadamu, Miyanaga, Naoto, ...

Background: Combination chemotherapy of methotrexate, actinomycin D and cisplatin (MAP) is reported to be effective against gestational choriocarcinoma. Methods: Eight patients with metastatic...

Paclitaxel, Ifosfamide and Cisplatin Regimen is Feasible for Japanese Patients with Advanced Germ Cell Cancer (2003)

Kawai, Koji, Miyazaki, Jun, Tsukamoto, Sadamu, Hinotsu, Shiro, Hattori, Kazunori, Shimazui, Toru, ...

Background: Paclitaxel, ifosfamide and cisplatin (TIP) has been tested with successful results on metastatic testicular cancer in Western countries. Because paclitaxel, the key drug of this regimen,...

Treated Natural History of Superficial Bladder Cancer (2001)

Ozono, Seiichiro, Hinotsu, Shiro, Tabata, Shoichi, Takashima, Kenji, Fujimoto, Kiyohide, Okajima, Eigoro, ...

Background: The present study was conducted to examine the natural history of superficial bladder cancer. Methods: One hundred and forty-four patients with superficial bladder cancer who had been...